Altria Group, Inc. (MO) Stock: Price, Forecast & Analyst Target
Altria Group, Inc. (MO) — MoonshotScore 94/100 (Exceptional band), calculated Nov 18, 2026. Price $74.68 (-2.07%), as of the Nov 19, 2026 trading session; market cap $124B. Expected results Feb 4, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Altria Group, Inc. · MO · NYSE · Consumer Defensive · Tobacco
Research dated 2026-09-12: Altria sells cigarettes, cigars, oral tobacco and nicotine pouches in the United States, chiefly through wholesalers and large retail chains. Marlboro-led smokeable products still dominate the revenue mix, making the durability of those economics—and the ability of smokeless products to become more consequential—the defining tension.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Altria Group (MO)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality and a strong balance sheet, but a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Full; Growth Durability: Flat; Momentum: Surging.
- EPS beat 0 of the last 4 reports
- expected results Feb 4, 2027
- Altman Z 5.27 · Piotroski F 7
Helping: business quality, balance-sheet strength, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 91 | Exceptional | |
| 91 | Exceptional | |
| 91 | Exceptional | |
| 91 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $74.68 | |
| Change on the day | -2.07% | |
| 52-week range | $54.70–$79.97 | |
| Market capitalisation | $124B | — |
| Price / earnings (trailing) | 15.97 | |
| Shares traded on the day | 8.44M | |
| Beta (volatility vs the S&P 500) | 0.46 |
Why Altria Group scores 94
Share price, last 12 months +32.6%
$57.55 $76.34
What the price assumes
2.3% a year of free-cash-flow growth for ten years is what a $126.99B market value ( snapshot) asks for.
The price already assumes faster growth than the last 5 years delivered. Anything short of an acceleration leaves room to disappoint. It also runs ahead of the analysts' revenue path.
Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $9.07B. Inputs: FMP statements, estimates and quote.
How the stock reacts to earnings
EPS beat in 4 of the last 12 reports (2024–2026); the stock still fell the next session after 0 of those beats. Average first-session move: 4.5% either way.
- +3.1%Feb ’24
- +1.1%Apr ’24
- -1.0%Jul ’24
- +6.7%Oct ’24
- -0.8%Jan ’25
- +1.6%Apr ’25
- +4.3%Jul ’25
- -9.0%Oct ’25
- -1.8%Jan ’26
- +9.3%Apr ’26
- -8.8%Jul ’26
- +6.9%Oct ’26
Every report, with revenue and five-session moves
| Report | EPS | Revenue | Next session | 5 sessions |
|---|---|---|---|---|
| In line | Beat | +6.9% | +6.3% | |
| Miss | In line | -8.8% | -9.6% | |
| Beat | Beat | +9.3% | +1.2% | |
| Miss | In line | -1.8% | +3.6% | |
| In line | In line | -9.0% | -7.6% | |
| Beat | Beat | +4.3% | +6.4% | |
| Beat | Miss | +1.6% | +3.9% | |
| In line | Beat | -0.8% | -0.0% | |
| Beat | In line | +6.7% | +6.0% | |
| Miss | Miss | -1.0% | -1.0% | |
| In line | In line | +1.1% | +2.5% | |
| In line | Beat | +3.1% | -0.1% |
Misses cost real money here: the average first-session move after a miss was -3.9%.
What management is saying differently
Management's own words on the Q3 FY2026 call () against Q2 FY2026 (). Analysts' questions are left out.
- New this call: “reduction opportunity”, “highly competitive”, “long-term harm”, “strong financial” — none of them came up in Q2 FY2026.
- Getting louder: “harm reduction” (3 → 7 mentions), “cigarette category” (2 → 4 mentions).
- Gone quiet: “disposable e-vapor”, “national expansion”, “pouch consumers”, “product portfolio” — regular themes last call, absent this time.
The tone held steady from one call to the next; what changed is the subject matter, not the confidence.
Our track record on this stock
Since the score went from 87 to 94 while the share price moved +9.1% through .
The score has stayed in the Exceptional band across the stretch we have recorded; we grade each band change three months after it happens.
The crowd against our signals
- Analysts: 62% of 26 rate it a buy; the average target sits -1.2% from the price of $74.68.
- Last 90 days: 4 rating actions, every one a reaffirmation.
- Our signals: Exceptional band; strongest pillar Business Quality (99), weakest Valuation (53).
Here we and the crowd agree. Where we differ is on price: our Valuation reading is more cautious than the analysts' targets.
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for Altria Group (MO): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Altria Group (MO), and what does it report?
Short answer · as of
Altria is a branded nicotine manufacturer and marketer rather than a retailer or a broadly diversified consumer-goods company.
Research dated 2026-09-12.
Marlboro anchors cigarettes, Black & Mild covers cigars and pipe tobacco, Copenhagen and Skoal lead moist smokeless tobacco, and on! extends the portfolio into oral nicotine pouches.
The reported segment view divides the business mainly between smokeable and smokeless products. Smokeables contribute overwhelmingly more revenue, so consolidated results still measure the performance of the combustible franchise far more than the progress of oral nicotine.
What do the latest results show for Altria Group (MO)?
Research dated 2026-09-12.
The latest income-statement period showed higher revenue, gross profit, operating profit and net income than the preceding period and the comparable prior annual period. The earnings comparison was less uniform: revenue exceeded consensus, while earnings per share came in slightly below expectations.
That improvement follows an annual pattern of gradually declining revenue and volatile net income. Because smokeables dominate segment revenue, group-level improvement is not yet evidence that the smaller smokeless portfolio has changed Altria’s economic center of gravity; it is best read as a stronger reported outcome rather than proof of a particular pricing, volume or mix driver.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $5.44B Oct 29, 2026
- Latest report · revenue estimate
- $5.31B Oct 29, 2026
- Latest report · revenue vs estimate
- Above estimate Oct 29, 2026
- Latest report · EPS vs estimate
- Above estimate Oct 29, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Oct 29, 2026 | $5.44B | $5.31B | $1.5200 | $1.5100 |
| Jul 30, 2026 | $5.36B | $5.35B | $1.4800 | $1.5000 |
| Apr 30, 2026 | $5.36B | $4.58B | $1.3200 | $1.2400 |
| Jan 29, 2026 | $5.08B | $5.03B | $1.3000 | $1.3200 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $5.25B | $2.38B | $1.41 (diluted) |
| Q4 FY2025 | $5.08B | $1.12B | — |
| Q1 FY2026 | $4.76B | $2.18B | $1.30 (diluted) |
| Q2 FY2026 | $5.36B | $2.30B | $1.37 (diluted) |
What are the financial strengths and risks for Altria Group (MO)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12.
Altria combines unusually high reported margins with modest capital expenditure, and its quality and distress screens are favorable. Operating cash flow has been substantial in many reporting periods, but the latest period turned negative despite strong accounting profit, showing that cash realization can be uneven.
Near-term cash and investments sit well below total debt. Including the larger pool of unclassified long-term investments narrows that gap, but those holdings should not be treated as equivalent to immediately available liquidity; negative equity also makes conventional leverage and return-on-equity ratios difficult to interpret.
The damaging combination would be weaker smokeable-product economics alongside persistently poor cash conversion. Smokeable concentration would transmit that pressure across the group, while the debt load would leave less room for cash-flow volatility.
What should you watch next at Altria Group (MO)?
Short answer · as of
The next earnings report is expected on Feb 4, 2027.
Research dated 2026-09-12.
Revenue quality deserves attention at the scheduled earnings release: watch for continued improvement in gross and operating profit, an earnings result that no longer trails consensus, and a rebound in operating cash flow. Agreement among those measures would be more informative than another isolated swing in net income.
Cash and short-term investments have declined from their recent peak across successive reporting periods, so stabilization there would strengthen the cash-conversion picture. The longer-range consensus path assumes gradual revenue and earnings growth; sustained top-line progress would support that path more directly than profit volatility.
Product mix remains the strategic checkpoint. Movement in smokeless revenue must become meaningful relative to the Marlboro-led smokeable base before the company’s dependence on combustible products materially changes.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does Altria Group compare with its peers?
Short answer
Altria Group's score ranks 1st of 11 in the bounded comparison shown, against 10 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Altria’s distinctive profile is a domestic portfolio spanning Marlboro cigarettes, Black & Mild cigars, established moist-smokeless brands and on! nicotine pouches, all routed largely through wholesale partners and major retail chains. Its breadth stays inside tobacco and nicotine rather than extending across unrelated consumer categories.
The financial resemblance to a mature tobacco business is clear in high margins, limited capital spending and strong cash generation during many periods. What separates the current mix from a balanced smoke-free model is the continuing revenue dominance of smokeable products, while leverage and uneven cash conversion remain important counterweights to those economics.
| Company | Price | Market value | Score |
|---|---|---|---|
| Altria Group (MO) — this page | $74.68 | $124B | 94 |
| $98.85 Nov 18, 2026 | $78.6B | 93 5-pillar Nov 18, 2026 | |
| $186.43 Nov 19, 2026 | $291B | 92 5-pillar Nov 18, 2026 | |
| $57.46 Nov 19, 2026 | $123B | 87 5-pillar Nov 18, 2026 | |
| $82.98 Nov 18, 2026 | $163B | 78 5-pillar Nov 18, 2026 | |
| $65.69 Nov 19, 2026 | $83.2B | 72 5-pillar Nov 18, 2026 | |
| $98.33 Nov 19, 2026 | $54.8B | 72 5-pillar Nov 18, 2026 | |
| $1.46 Nov 19, 2026 | $1.78B | 67 5-pillar Nov 18, 2026 | |
| $47.53 Nov 18, 2026 | $945M | 57 5-pillar Nov 18, 2026 | |
| $32.97 Nov 19, 2026 | $822M | 47 5-pillar Nov 18, 2026 | |
| $0.76 Nov 19, 2026 | — | 16 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $58.00 – $85.00
- Consensus target
- $73.80
- Median target
- $83.00
Consensus record · Captured .
Measured against a quoted price of $74.68 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 14, 2026
- Transactions
- 4
- Identified insiders
- 4
- Purchases
- 1
- Sales
- 2
- Other transactions
- 1
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MO in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 0.62% | $141.46M | Added +21.6% shares |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About MO (Consumer Defensive)
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Why does Marlboro matter more than on! to Altria today?
Marlboro sits within the smokeable franchise, which overwhelmingly dominates reported segment revenue, while on! belongs to the much smaller smokeless portfolio. Near-term group economics are therefore more sensitive to smokeables than to the present scale of oral nicotine pouches.
How do Altria’s wholesale partners and major chain stores reach nicotine consumers?
Altria primarily sells through independent distributors and directly to large retail organizations. Consumer demand reaches Altria through product movement across those channels rather than through a company-operated store network.
What do Copenhagen, Skoal and on! add to Altria’s portfolio?
Copenhagen and Skoal provide established moist-smokeless offerings, while on! adds oral nicotine pouches. These products broaden the available formats, but their segment remains far smaller than smokeable products.
Why are Black & Mild and Marlboro part of Altria’s smokeable business?
Marlboro is the principal cigarette brand, whereas Black & Mild is concentrated in cigars and pipe tobacco. The formats differ, but each belongs to Altria’s combustible product portfolio and reinforces the company’s exposure to smokeable categories.
What is the MO stock price today?
The last price recorded for Altria Group, Inc. (MO), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the MO price target?
The analyst consensus price target for Altria Group, Inc. (MO), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 41 figures on this page — 1 from SEC filings and earnings calls, 34 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-12), by section of the research
ETFs that hold MO
Funds in our ETF coverage that list MO among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
